available 24/7
available 24/7
partner
Three former salespeople say Johnson & Johnson’s Janssen Pharmaceutical unit encouraged sales representatives to promote its anti-psychotic Risperdal for uses not approved by the FDA.
PKSD is a Milwaukee personal injury law firm handling drug injury cases through out the state. Our personal injury lawyers have successfully represented injured people in almost every county.
In order to boost the sales of the drug, J&J urged doctors to prescribe Risperdal for bipolar disorder and depression.
Nine states have sued J&J, claiming it violated a federal bar to off-label marketing. Off-label marketing or promotion involves marketing drugs for unapproved uses. While drug-makers are not allowed to market their drugs for off-label uses, doctors are permitted to prescribe medicines for conditions not approved by the FDA. In fact, according to Dr. Jeffrey Lieberman of Columbia University Medical Center, off-label prescribing is done all the time in the practice of medicine in a very rational and useful way.
Recently, Pfizer agreed to pay $2.3 billion to end an investigation into their marketing tactics over the painkiller Bextra. Eli Lilly said it would pay $1.42 billion over promotion of Zyprexa.
According to the lawsuit, one salesperson was encouraged by her superiors to prescribe Risperdal for depression, anxiety and other unapproved uses, and she was praised for expanding the market. J&J went so far as to offer bonuses for boosting sales.
This page has been written, edited, and reviewed by a team of legal writers following our comprehensive editorial guidelines. This page was approved by attorney Jeffery A. Pitman, who has more than 28 years of legal experience and handled thousands of personal injury cases while obtaining millions of dollars in verdicts and settlements in Wisconsin, Illinois, Iowa and New Mexico.
In this month’s edition of the PKSD Newsletter, You Should Know, we cover the opioid epidemic and the lawsuits being filed by state, county...
The following products have been recalled by the FDA for various reasons. For more information, please go to www.fda.gov. Rushing Waters Fisheries, Palmyra, is...
A new report released by the Government Accountability Office (GAO) reveals disturbing gaps in the the Food and Drug Administrations (FDA) tracking of drug...
